Novel antifungal agents: a patent review (2011 - present). (Q38176048)

30 August 2017

Novel antifungal agents: a patent review (2011 - present). (English)

1 reference

30 August 2017

María Victoria Castelli

1

1 reference

30 August 2017

Estefanía Butassi

2

1 reference

30 August 2017

María Candida Monteiro

3

1 reference

30 August 2017

Laura A Svetaz

4

1 reference

30 August 2017

Francisca Vicente

5

1 reference

30 August 2017

Susana A Zacchino

6

1 reference

30 August 2017

language of work or name

English

0 references

publication date

7 January 2014

1 reference

Expert Opinion on Therapeutic Patents

30 August 2017

1 reference

30 August 2017

24

1 reference

30 August 2017

323-338

1 reference

30 August 2017

3

1 reference

Epidemiology of invasive candidiasis: a persistent public health problem

30 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Hidden killers: human fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Therapy for fungal diseases: opportunities and priorities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Systemic mycoses in the immunocompromised host: an update in antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Changing epidemiology of systemic fungal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

[Antifungals for systemic use].

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Recent approaches to antifungal therapy for invasive mycoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

An insight into the antifungal pipeline: selected new molecules and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

New lead structures in antifungal drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Novel small molecules for the treatment of infections caused by Candida albicans: a patent review (2002-2010).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Invasive mycoses: strategies for effective management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Amphotericin B and its new derivatives - mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Management of invasive fungal infections: a role for polyenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Current and future antifungal therapy: new targets for antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

New therapeutic options for onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

The structure and synthesis of the fungal cell wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

The cell wall: a carbohydrate armour for the fungal cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Tasting the fungal cell wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

The structure of cell wall alpha-glucan from fission yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Distribution of chitin in the yeast cell wall. An ultrastructural and chemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Chitin synthesis and fungal pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Chitin synthesis as target for antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Cloning and characterization of a chitinase-encoding gene (chiA) from Aspergillus nidulans, disruption of which decreases germination frequency and hyphal growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Candida albicans cell wall glycans, host receptors and responses: elements for a decisive crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Chemical biology of glycosylphosphatidylinositol anchors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Biosynthesis and function of GPI proteins in the yeast Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Echinocandins: the newest class of antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Echinocandins: are they all the same?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Anidulafungin: a novel echinocandin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Comparison of echinocandin antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Echinocandin antifungal drugs in fungal infections: a comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Fungal ß(1,3)-D-glucan synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Human pharmacogenomic variations and their implications for antifungal efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Echinocandin antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Optimizing antifungal choice and administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Echinocandin antifungals: review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Anidulafungin: a new echinocandin with a novel profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Synthesis and biological evaluation of antifungal derivatives of enfumafungin as orally bioavailable inhibitors of β-1,3-glucan synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

HWY-289, a novel semi-synthetic protoberberine derivative with multiple target sites in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Investigation of family 18 chitinases and inhibitors by computer-aided approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Antimicrobial peptides: therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

Antimicrobial peptides: general overview and clinical implications in human health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.876993

10.1517/13543776.2014.876993

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference